[go: up one dir, main page]

AU2001261694A1 - Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior - Google Patents

Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior

Info

Publication number
AU2001261694A1
AU2001261694A1 AU2001261694A AU6169401A AU2001261694A1 AU 2001261694 A1 AU2001261694 A1 AU 2001261694A1 AU 2001261694 A AU2001261694 A AU 2001261694A AU 6169401 A AU6169401 A AU 6169401A AU 2001261694 A1 AU2001261694 A1 AU 2001261694A1
Authority
AU
Australia
Prior art keywords
aminotetralins
behavior
derivatives
receptor activity
exhibiting differential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261694A
Inventor
Aloke K. Dutta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayne State University
Original Assignee
Wayne State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wayne State University filed Critical Wayne State University
Publication of AU2001261694A1 publication Critical patent/AU2001261694A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001261694A 2000-05-19 2001-05-17 Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior Abandoned AU2001261694A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20577900P 2000-05-19 2000-05-19
US60205779 2000-05-19
PCT/US2001/015915 WO2001089453A2 (en) 2000-05-19 2001-05-17 Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior

Publications (1)

Publication Number Publication Date
AU2001261694A1 true AU2001261694A1 (en) 2001-12-03

Family

ID=22763611

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261694A Abandoned AU2001261694A1 (en) 2000-05-19 2001-05-17 Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior

Country Status (3)

Country Link
US (1) US7049337B2 (en)
AU (1) AU2001261694A1 (en)
WO (1) WO2001089453A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041478A1 (en) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh New pharmaceutical composition
DE10137633A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Treatment or prophylaxis of attention deficit hyperactivity disorder, using the dopamine agonist pramexipol or its salt
US8865287B2 (en) * 2008-08-13 2014-10-21 Robert A. Haupt Rapid curing aldehyde resin-polyisocyanate composition and method for producing hybrid polymer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545755A (en) * 1989-05-31 1996-08-13 The Upjohn Company Therapeutically useful 2-aminotetralin derivatives
DE3919624A1 (en) * 1989-06-15 1990-12-20 Boehringer Ingelheim Kg NEW 2,5-DIAMINOTETRALINE, METHOD FOR THE PRODUCTION THEREOF, AND ITS USE AS A MEDICAMENT
WO1994022495A1 (en) * 1993-03-31 1994-10-13 The Trustees Of The University Of Pennsylvania Dopamine d-3 and serotonin (5-ht1a) receptor ligands and imaging agents
DK1083889T3 (en) * 1998-06-01 2004-04-13 Ortho Mcneil Pharm Inc Tetrahydronaphthalene compounds and their use in the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
WO2001089453A2 (en) 2001-11-29
WO2001089453A3 (en) 2002-03-28
US20030225154A1 (en) 2003-12-04
US7049337B2 (en) 2006-05-23

Similar Documents

Publication Publication Date Title
AU2001235691A1 (en) Use of paullone derivatives for making medicines
HUP0301269A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
PT1221918E (en) ADMINISTRATION OF SUB-TENON DRUGS
AU2001231000A1 (en) Dry powder formulations of antihistamine for nasal administration
WO2002011728A3 (en) Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation
HUP0302412A3 (en) Betha-carboline derivatives useful as inhibitors of phosphodiesterase and pharmaceutical compositions containing the same
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2177001A (en) Use of indirubine derivatives for making medicines
AU2001278821A1 (en) Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
HUP0303364A3 (en) Pyrimidine derivatives of arylalkane-sulfonamides having endothelin-antagonist activity, pharmaceutical compositions containing them and their use
HUP0104175A3 (en) Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU9416201A (en) Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
AU2001297611A1 (en) Pharmaceutical uses and synthesis of diketopiperazines
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
AU2002230781A1 (en) Pharmaceutical uses and synthesis of benzobicyclooctanes
AU2001261694A1 (en) Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior
AU4307800A (en) New indication for use of antiepileptic agents and medicines
HUP0300557A3 (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
EP0996441A4 (en) Pharmaceutical compositions of arglabin and arglabin derivatives
HUP0200993A3 (en) Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
AU2002212863A1 (en) Stable pharmaceutical form of an anticancer drug
AU2001264900A1 (en) Pharmaceutical use of fibulin-1
AU2001228784A1 (en) Inositol derivatives and their pharmaceutical use